Biosimilars, the journey has begun
According to the European Medicine Agency, a “biosimilar” is a biological medicinal product that contains a version of the active substance of an original biological medicinal product (reference or innovative medicinal product) that has been authorized in the European Economic Area. The similarity...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Grupo Aula Médica
2015-01-01
|
Series: | Farmacia Hospitalaria |
Subjects: | |
Online Access: | http://www.aulamedica.es/fh/pdf/8789.pdf |